BRKR RSI Chart
Last 7 days
-0.9%
Last 30 days
-9.5%
Last 90 days
-8.3%
Trailing 12 Months
0.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 3.0B | 0 | 0 | 0 |
2023 | 2.6B | 2.7B | 2.8B | 3.0B |
2022 | 2.5B | 2.5B | 2.5B | 2.5B |
2021 | 2.1B | 2.3B | 2.4B | 2.4B |
2020 | 2.0B | 2.0B | 2.0B | 2.0B |
2019 | 1.9B | 2.0B | 2.0B | 2.1B |
2018 | 1.8B | 1.8B | 1.9B | 1.9B |
2017 | 1.6B | 1.7B | 1.7B | 1.8B |
2016 | 1.6B | 1.6B | 1.6B | 1.6B |
2015 | 1.7B | 1.7B | 1.7B | 1.6B |
2014 | 1.9B | 1.9B | 1.9B | 1.8B |
2013 | 1.8B | 1.8B | 1.8B | 1.8B |
2012 | 1.7B | 1.7B | 1.7B | 1.8B |
2011 | 1.4B | 1.5B | 1.6B | 1.7B |
2010 | 1.2B | 1.2B | 1.3B | 1.3B |
2009 | 0 | 0 | 0 | 1.1B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 04, 2024 | requardt hermann fritz | sold | -1,350,900 | 90.0599 | -15,000 | - |
Mar 04, 2024 | requardt hermann fritz | acquired | 330,750 | 22.05 | 15,000 | - |
Feb 28, 2024 | busse falko | sold | -2,403,890 | 85.4808 | -28,122 | president, biospin group |
Feb 28, 2024 | busse falko | acquired | 739,156 | 26.2839 | 28,122 | president, biospin group |
Feb 22, 2024 | prause burkhard | sold | -1,276,070 | 83.3 | -15,319 | pres. & ceo, bruker best |
Feb 22, 2024 | prause burkhard | acquired | 235,292 | 43.1728 | 5,450 | pres. & ceo, bruker best |
Jan 05, 2024 | requardt hermann fritz | acquired | - | - | 2,377 | - |
Jan 05, 2024 | rosenthal bob | acquired | - | - | 2,377 | - |
Jan 05, 2024 | packer richard a | acquired | - | - | 2,377 | - |
Jan 05, 2024 | ma philip | acquired | - | - | 2,377 | - |
Which funds bought or sold BRKR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | FSA Wealth Management LLC | unchanged | - | 3,091 | 14,091 | 0.01% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -16.68 | 523,468 | 8,558,870 | 0.01% |
May 16, 2024 | COMERICA BANK | reduced | -2.9 | 707,324 | 3,638,100 | 0.02% |
May 16, 2024 | Beacon Capital Management, LLC | sold off | -100 | -1,433 | - | -% |
May 16, 2024 | Pineridge Advisors LLC | sold off | -100 | -1,617 | - | -% |
May 16, 2024 | Tidal Investments LLC | new | - | 217,941 | 217,941 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -78.97 | -4,964,690 | 1,825,820 | -% |
May 15, 2024 | FARALLON CAPITAL MANAGEMENT LLC | added | 2,670 | 7,585,970 | 7,806,410 | 0.04% |
May 15, 2024 | CAPITAL FUND MANAGEMENT S.A. | reduced | -11.68 | 1,210,950 | 10,589,200 | 0.03% |
May 15, 2024 | Mariner, LLC | added | 0.12 | 117,475 | 537,611 | -% |
Unveiling Bruker Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Bruker Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.1M | 3.7M | -0.09 | 0.29 |
Bruker Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -15.5% | 722 | 855 | 743 | 682 | 685 | 708 | 639 | 588 | 595 | 684 | 609 | 571 | 555 | 628 | 511 | 425 | 424 | 600 | 521 | 490 | 461 |
Cost Of Revenue | -13.0% | 369 | 424 | 360 | 341 | 326 | 343 | 304 | 290 | 289 | 342 | 300 | 290 | 276 | 315 | 263 | 238 | 232 | 304 | 267 | 260 | 247 |
Gross Profit | -18.0% | 353 | 430 | 383 | 341 | 360 | 366 | 335 | 298 | 306 | 342 | 309 | 281 | 279 | 313 | 248 | 186 | 192 | 296 | 254 | 230 | 215 |
Operating Expenses | -11.9% | 288 | 327 | 258 | 254 | 237 | 235 | 204 | 224 | 210 | 216 | 196 | 195 | 190 | 200 | 167 | 148 | 176 | 179 | 166 | 177 | 173 |
S&GA Expenses | -7.5% | 195 | 211 | 178 | 178 | 163 | 165 | 145 | 152 | 146 | 153 | 141 | 135 | 132 | 130 | 115 | 102 | 121 | 130 | 125 | 125 | 120 |
R&D Expenses | -2.0% | 82.00 | 84.00 | 71.00 | 71.00 | 69.00 | 64.00 | 56.00 | 60.00 | 57.00 | 58.00 | 52.00 | 56.00 | 55.00 | 57.00 | 48.00 | 44.00 | 49.00 | 47.00 | 46.00 | 49.00 | 46.00 |
EBITDA Margin | -4.8% | 0.22* | 0.23* | 0.20* | 0.20* | 0.21* | 0.21* | 0.21* | 0.20* | 0.21* | 0.21* | 0.21* | 0.20* | - | - | - | - | - | - | - | - | - |
Income Taxes | -46.6% | 20.00 | 37.00 | 31.00 | 20.00 | 30.00 | 23.00 | 41.00 | 20.00 | 32.00 | 44.00 | 21.00 | 21.00 | 28.00 | 34.00 | 20.00 | 7.00 | 3.00 | 42.00 | 22.00 | 11.00 | 8.00 |
Earnings Before Taxes | -70.3% | 72.00 | 241 | 119 | 78.00 | 107 | 121 | 129 | 70.00 | 94.00 | 120 | 109 | 80.00 | 85.00 | 106 | 75.00 | 31.00 | 14.00 | 111 | 83.00 | 48.00 | 38.00 |
EBT Margin | -7.6% | 0.17* | 0.18* | 0.15* | 0.16* | 0.16* | 0.16* | 0.16* | 0.16* | 0.16* | 0.16* | 0.16* | 0.15* | - | - | - | - | - | - | - | - | - |
Net Income | -75.2% | 51.00 | 206 | 88.00 | 57.00 | 77.00 | 97.00 | 88.00 | 50.00 | 62.00 | 76.00 | 87.00 | 58.00 | 57.00 | 69.00 | 54.00 | 24.00 | 11.00 | 69.00 | 61.00 | 37.00 | 31.00 |
Net Income Margin | -7.1% | 0.13* | 0.14* | 0.11* | 0.12* | 0.12* | 0.12* | 0.11* | 0.11* | 0.11* | 0.11* | 0.11* | 0.10* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -99.8% | 0.00 | 174 | 17.00 | -10.50 | 63.00 | 137 | 12.00 | -62.30 | 59.00 | 110 | 8.00 | -0.70 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 6.0% | 4,506 | 4,250 | 3,820 | 3,857 | 3,764 | 3,612 | 3,337 | 3,385 | 3,551 | 3,650 | 3,128 | 3,087 | 3,035 | 3,049 | 2,879 | 2,943 | 2,962 | 2,772 | 2,352 | 2,350 | 2,243 |
Current Assets | -1.1% | 2,140 | 2,164 | 2,029 | 2,183 | 2,133 | 2,113 | 2,037 | 2,088 | 2,251 | 2,472 | 1,989 | 1,968 | 1,946 | 1,925 | 1,826 | 1,957 | 1,990 | 1,796 | 1,434 | 1,406 | 1,344 |
Cash Equivalents | -29.7% | 343 | 488 | 364 | 575 | 598 | 646 | 629 | 726 | 820 | 1,072 | 577 | 612 | 700 | 686 | 571 | 750 | 799 | 682 | 300 | 287 | 303 |
Inventory | 9.5% | 1,061 | 968 | 916 | 915 | 859 | 800 | 750 | 759 | 740 | 710 | 733 | 730 | 701 | 692 | 696 | 665 | 626 | 577 | 587 | 595 | 542 |
Net PPE | -2.3% | 586 | 600 | 527 | 523 | 511 | 487 | 422 | 395 | 404 | 406 | 389 | 398 | 384 | 396 | 355 | 336 | 319 | 306 | 278 | 282 | 268 |
Goodwill | 29.1% | 752 | 583 | 561 | 558 | 527 | 458 | 382 | 396 | 384 | 340 | 324 | 315 | 313 | 320 | 313 | 295 | 290 | 293 | 282 | 285 | 6.00 |
Liabilities | 7.7% | 3,056 | 2,837 | - | - | - | 2,480 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Liabilities | -1.6% | 1,183 | 1,202 | 1,072 | 1,051 | 1,049 | 914 | 865 | 818 | 881 | 939 | 921 | 955 | 944 | 792 | 683 | 750 | 766 | 646 | 643 | 641 | 633 |
Long Term Debt | 17.0% | 1,357 | 1,160 | 1,099 | 1,123 | 1,109 | 1,201 | 1,137 | 1,171 | 1,205 | 1,222 | 718 | 721 | 716 | 842 | 828 | 924 | 915 | 813 | 519 | 494 | 332 |
LT Debt, Non Current | -100.0% | - | 1,160 | 1,099 | 1,123 | 1,109 | 1,201 | 1,137 | 1,171 | 1,205 | 1,222 | 718 | 721 | 716 | 842 | 828 | 924 | 915 | 813 | 519 | 494 | - |
Shareholder's Equity | 4.0% | 1,433 | 1,377 | 1,209 | 1,251 | 1,199 | 1,114 | 948 | 984 | 1,031 | 1,085 | 1,090 | 1,015 | 982 | 974 | 963 | 907 | 925 | 917 | 855 | 870 | 922 |
Retained Earnings | 1.9% | 2,367 | 2,324 | - | - | - | 1,926 | - | - | - | 1,660 | - | - | - | 1,407 | - | - | - | 1,275 | - | - | - |
Additional Paid-In Capital | 2.9% | 291 | 283 | - | - | - | 256 | - | - | - | 238 | - | - | - | 216 | - | - | - | 200 | - | - | - |
Shares Outstanding | 0.1% | 145 | 145 | 146 | 147 | 147 | 147 | 147 | 148 | 149 | 151 | 152 | 151 | - | - | - | - | - | - | - | - | - |
Minority Interest | 1.1% | 18.00 | 17.00 | 18.00 | 20.00 | 19.00 | 12.00 | 11.00 | 14.00 | 14.00 | 14.00 | 14.00 | 13.00 | 14.00 | 13.00 | 11.00 | 9.00 | 9.00 | 10.00 | 10.00 | 9.00 | 8.00 |
Float | - | - | - | - | 6,099 | - | - | - | 4,001 | - | - | - | 4,040 | - | - | - | 2,173 | - | - | - | 5,068 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -89.4% | 21,800 | 205,500 | 44,100 | 13,000 | 87,500 | 171,500 | 69,500 | -44,400 | 77,800 | 138,600 | 23,900 | 21,900 | 98,000 | 203,000 | 82,400 | 11,800 | 35,000 | 136,200 | 52,400 | 10,600 | 14,200 |
Share Based Compensation | -14.5% | 5,300 | 6,200 | 5,700 | 5,600 | 6,500 | 4,700 | 5,300 | 9,700 | 8,000 | 5,300 | 4,200 | 3,900 | 3,800 | 5,100 | 4,500 | 3,100 | 3,300 | -500 | 4,000 | 3,000 | 3,100 |
Cashflow From Investing | -726.6% | -304,200 | -36,800 | -155,000 | -26,000 | -108,200 | -149,300 | -57,600 | 57,100 | -101,800 | -48,600 | -48,400 | -71,400 | -24,000 | -28,800 | -48,200 | -15,100 | -100,600 | -39,200 | -12,600 | -79,900 | -26,700 |
Cashflow From Financing | 353.3% | 151,700 | -59,900 | -92,500 | -10,300 | -30,700 | -36,100 | -82,000 | -79,800 | -217,400 | 404,300 | -2,600 | -44,900 | -38,100 | -74,300 | -225,500 | -53,100 | 191,300 | 277,900 | -19,500 | 50,400 | -8,800 |
Dividend Payments | 0% | 7,300 | 7,300 | 7,400 | 7,300 | 7,400 | 7,400 | 7,400 | 7,500 | 7,500 | 6,000 | 6,100 | 6,000 | 6,100 | 6,100 | 6,200 | 6,100 | 6,200 | 6,200 | 6,200 | 6,300 | 6,300 |
Buy Backs | -100.0% | - | 50,400 | 80,300 | 100 | 22,300 | 25,550 | 72,400 | 60,300 | 105,600 | 82,200 | - | 38,300 | 32,800 | 68,800 | 5,000 | 50,000 | - | - | 42,300 | 100,000 | - |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Total revenue | $ 721.7 | $ 685.3 |
Total cost of revenue | 368.9 | 325.6 |
Gross profit | 352.8 | 359.7 |
Operating expenses: | ||
Selling, general and administrative | 195.3 | 162.7 |
Research and development | 81.8 | 69.0 |
Other charges, net | 10.9 | 5.3 |
Total operating expenses | 288.0 | 237.0 |
Operating income | 64.8 | 122.7 |
Interest and other income (expense), net | 6.8 | (16.1) |
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries | 71.6 | 106.6 |
Income tax provision | 19.8 | 29.9 |
Equity in income of unconsolidated investees, net of tax | 0.2 | 0.7 |
Net income | 52.0 | 77.4 |
Net income attributable to noncontrolling interests in consolidated subsidiaries | 1.1 | 0.9 |
Net income attributable to Bruker Corporation | $ 50.9 | $ 76.5 |
Net income per common share attributable to Bruker Corporation shareholders: | ||
Basic | $ 0.35 | $ 0.52 |
Diluted | $ 0.35 | $ 0.52 |
Weighted average common shares outstanding: | ||
Basic | 145.2 | 146.8 |
Diluted | 145.9 | 147.6 |
Product | ||
Total revenue | $ 586.9 | $ 567.1 |
Total cost of revenue | 291.7 | 257.2 |
Other | ||
Total revenue | 134.8 | 118.2 |
Total cost of revenue | $ 77.2 | $ 68.4 |
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 340.1 | $ 488.3 |
Accounts receivable, net | 475.4 | 492.0 |
Inventories | 1,060.5 | 968.3 |
Other current assets | 264.4 | 215.6 |
Total current assets | 2,140.4 | 2,164.2 |
Property, plant and equipment, net | 586.1 | 599.7 |
Goodwill | 751.9 | 582.6 |
Intangible assets, net | 449.2 | 330.5 |
Operating lease assets | 105.1 | 91.7 |
Deferred tax assets | 280.1 | 297.2 |
Other long-term assets | 193.6 | 184.0 |
Total assets | 4,506.4 | 4,249.9 |
Current liabilities: | ||
Current portion of long-term debt | 21.2 | 121.2 |
Accounts payable | 199.1 | 202.7 |
Deferred revenue and customer advances | 485.2 | 400.0 |
Other current liabilities | 477.0 | 478.2 |
Total current liabilities | 1,182.5 | 1,202.1 |
Long-term debt | 1,357.3 | 1,160.3 |
Long-term deferred revenue and customer advances | 105.6 | 91.5 |
Deferred tax liabilities | 81.8 | 67.7 |
Operating lease liabilities | 85.7 | 74.8 |
Accrued pension | 76.0 | 76.6 |
Other long-term liabilities | 166.7 | 163.6 |
Total liabilities | 3,055.6 | 2,836.6 |
Commitments and contingencies (Note 16) | ||
Redeemable noncontrolling interests | 17.9 | 18.7 |
Shareholders' equity: | ||
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding | 0.0 | 0.0 |
Common stock, $0.01 par value 260,000,000 shares authorized, 176,113,521 and 175,943,705 shares issued and 145,334,642 and 145,164,826 shares outstanding at March 31, 2024 and December 31, 2023, respectively. | 1.7 | 1.7 |
Treasury stock, at cost, 30,778,879 shares at March 31, 2024, and December 31, 2023, respectively | (1,237.2) | (1,237.2) |
Additional paid-in capital | 291.1 | 282.9 |
Retained earnings | 2,367.4 | 2,323.8 |
Accumulated other comprehensive (loss) income, net of tax | (7.7) | 6.0 |
Total shareholders' equity attributable to Bruker Corporation | 1,415.3 | 1,377.2 |
Noncontrolling interests in consolidated subsidiaries | 17.6 | 17.4 |
Total shareholders' equity | 1,432.9 | 1,394.6 |
Total liabilities, redeemable noncontrolling interests and shareholders' equity | $ 4,506.4 | $ 4,249.9 |